Back

A dipeptidyl peptidase-IV inhibitor attenuates cardiac fibrosis and improves diastolic dysfunction in Dahl salt-sensitive rats.

29 August 2016 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 4 - Heart failure/LV dysfunction Diastolic dysfunction ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Shin Ito

National Cerebral and Cardiovascular Center Hospital, Osaka (Japan)

48 More presentations in this session

Presentation thumbnail
Doctor C. Adlbrecht (Vienna, AT)
Abstract Slides
Presentation thumbnail
Doctor A. Iacovoni (Bergamo, IT)
Abstract Slides
Presentation thumbnail
Doctor G. Careri (Rome, IT)
Abstract Slides
Presentation thumbnail
Professor L. Zhong (Singapore, SG)
Abstract
Presentation thumbnail
Mrs P. Gehle (Berlin, DE)
Abstract Slides

Access the full session

Session thumbnail
Poster session 4 - Heart failure/LV dysfunction

The Event

Event poster

ESC Congress 2016

29 August 2016 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Dipeptidyl peptidase-3, a marker of the antagonist pathway of the renin-angiotensin-aldosterone system in patients with heart failure
30 June 2021
thumbnail
Webinar
The role of imaging in the diabetic heart
6 October 2022
thumbnail
Congress Presentation
Relationship of myocardial fibrosis markers with cardiac structural and functional parameters in patients with post-myocardial infarction.
29 June 2021
thumbnail
Congress Presentation
Cardiac diastolic dysfunction in angiotensin II-treated hypertensive rats is associated with endothelial upregulation of SGLT1/2 in the macro and microcirculation: Protective effect of empagliflozin
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources